The Task Force began with a review of the latest scientific evidence, guidance, and opinion statements from relevant professional societies on the appropriate and effective use of therapeutic hypothermia for neonates presenting with symptoms of encephalopathy. That review was based on guidelines from the 2014 joint Task Force Report on Neonatal Encephalopathy and Neurologic Outcome by The American College of Obstetricians and Gynecologists (The College) and the American Academy of Pediatrics (AAP). Further insights were gathered from AMC PSO member subject matter experts in Neonatology, Neurology, Maternal Fetal Medicine, Obstetrics and Gynecology, and Pediatrics.
Over the course of 18 months, the Task Force generated a list of recommendations for the identification and management of suspected neonatal encephalopathy. While the core focus of these guidelines is infant screening and eligibility, the guidelines also address several other areas critical to the treatment of suspected neonatal encephalopathy, including:
• exclusion criteria
What follows is a document that reflects the aim, mission, and consensus opinion of the Neonatal Encephalopathy Task Force. It offers guidance for clinicians in their efforts to provide the safest, most effective, evidenced-based approach to care delivery. • Neonatal encephalopathy examination to be completed and documented by a Licensed Independent Provider as soon as possible, following admission of any neonate meeting at least one criterion (e.g., Apgar score, sentinel event, pH, or base excess (BE)) for therapeutic hypothermia or any neonate with findings of encephalopathy.
• If the neonate is being considered for therapeutic hypothermia and a definitive decision has not yet been reached, a repeat exam, ideally by the same Licensed Independent Provider (to maintain continuity), should be performed within the first hour to evaluate evolution of neonatal encephalopathy.
SCREENING CRITERIA
Neonates ≥ 34 weeks gestational age Concern for encephalopathy or seizure event
Any one of the following:
• sentinel event prior to delivery such as uterine rupture, profound bradycardia, or cord prolapse
• low Apgar scores ➔ ≤ 5 at 10 minutes of life
• prolonged resuscitation at birth ➔ chest compressions, and/or intubation, and/or mask ventilation at 10 minutes
• acidosis ➔ pH < 7.1 from cord or patient blood gas within 60 minutes of birth
• abnormal base excess ➔ ≤ -10 mEq/L from cord gas or patient blood gas within 60 minutes of birth and and
Identification of At-risk Neonates

Absolute Exclusion Criteria
• gestational age < 34 weeks
Relative Exclusion Criteria
(at the discretion of the accepting attending physician at the Level III facility) 
Therapeutic Hypothermia Is Indicated
Must fulfill all three criteria. Additional, separate, written parental consent is not legally required.
Neonates ≥ 36 weeks gestational age and less than 6 hours of age
• sentinel event prior to delivery, such as uterine rupture, profound fetal bradycardia, or cord prolapse
• prolonged resuscitation at birth ➔ chest compressions and/or intubation and/or mask ventilation at 10 minutes
• severe acidosis ➔ pH < 7.0 from cord or neonate blood gas within 60 minutes of birth
• abnormal base excess ➔ ≤ -16 mEq/L from cord gas or neonate blood gas within 60 minutes of birth Any one of the following:
• clinical event concerning for seizure
• neonatal encephalopathy (defined as a clinical exam* consistent with abnormal neurological findings by a standardized evaluation tool)** * If exam is unreliable, an EEG may be a useful adjunct tool for assessing and qualifying neonatal encephalopathy.
** To support alignment and continuity of care between referring and accepting neonatal units, the Neonatal Task Force recommends that institutions adopt a standardized, mutually agreeable assessment tool that meets the needs of the providers and the patient population served. 
Therapeutic Hypothermia Should Be Considered
In the setting of neonatal encephalopathy or concern for seizure with the less rigid criteria listed below.* Shared medical decision-making should be documented. Additional, separate written, parental consent may be required, as guided by institutional policy.
Neonates ≥ 34 weeks gestational age and up to 12 hours of age
• acidosis ➔ pH < 7.1 from cord or neonate blood gas within 60 minutes of birth
• abnormal base excess ➔ ≤ -10 mEq/L from cord gas or neonate blood gas within 60 minutes of birth
• post-natal collapse resulting in hypoxicischemic injury (i.e., near-SIDS type event)
• neonatal encephalopathy (defined as a clinical exam** consistent with abnormal neurological findings by a standardized evaluation tool)*** Passive Cooling
• Passive cooling should be initiated as soon as a potentially eligible neonate is identified, ideally in the delivery room (core temperature should be monitored).
-Turn off radiant warmers or isolette heaters (including transport isolette).
• Target core temperature (rectal or esophageal) for therapeutic cooling is 33.5 °C ± 1 °C.
-Do not use skin thermometers.
-Core temperature should be monitored every 5-15 minutes.
-Slowly titrate heat source as needed to achieve target temperature.
Note: If neonate has never been warmed, they are easily over-cooled, even passively.
-Once core temperature falls to 34 °C, have external heat source available set at 33.5 °C.
• Continue close monitoring to prevent rapid rewarming.
Initial Stabilization and Management in the Community Setting
• If core temperature rises above 34 °C, try opening isolette port(s) or unwrapping neonate.
-Caution: asphyxiated neonates have depressed metabolism, so generate less heat. Severely asphyxiated newborns can be quickly over-cooled with removal of radiant heat source.
-Cooled neonates will have a low resting heart rate, often in the 80-100 range and sometimes slightly lower.
• Passive cooling (with core temperature monitoring) should continue on transport if thermoregulated cooling is not available for the transport. Active cooling should be initiated immediately upon arrival to accepting center.
Blood Gases
• There should be a low threshold for obtaining cord gases or early neonate blood gases.
• If cord gases are not obtained or there are ongoing concerns, neonatal blood gases should be sent within the first hour of birth. Repeat as appropriate. -IV access becomes more difficult to obtain as core temperature decreases.
Labs
• Complete blood count (CBC) with differential.
• Electrolytes, magnesium, calcium, glucose.
• Blood cultures.
• Arterial blood gas (ABG) (with measured lactate, if possible).
• Liver function tests (LF Ts).
• Coagulation studies in Level III facilities.
Respiratory
• If receiving mechanical ventilation, do not over-ventilate.
-Target SpO 2 94-99%.
-Target pCO 2 40-50 mm Hg.
Cardiovascular
• Support and maintain blood pressure in normal range with fluids and pressors, as indicated.
• Neonate may become bradycardic (< 100 bpm) when temperature < 34 °C.
Infectious Disease
• Evaluate for suspected sepsis-treat appropriately. Avoid aminoglycosides.
Fluid and Electrolytes
• Avoid administering sodium bicarbonate (NaHCO 3 ), as acidosis will slowly correct.
• Nothing by mouth (NPO).
Neurological Care
• Neurological consult in Level III centers.
• Obtain full channel EEG for a minimum of 24 hours monitoring, when available.
• First choice agent for treating seizures: phenobarbital.
-Consider prophylactic phenobarbital, in consultation with the accepting center, in the setting of an intubated neonate with moderate to severe encephalopathy in the community setting.
Avoid Over Sedation
• Gentle sedation during initial stabilization and transport, if needed.
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After Admission to the NICU (Cooling Center)
• The target core temperature for therapeutic cooling is 33.5 °C ± 1 °C.
• Secure vascular access:
-Establish venous access, as soon as possible. Scalp IV is not ideal and may need to be removed for EEG lead placement.
-Establish umbilical venous access (UVC)-double lumen-if possible.
-Do not delay the commencement of therapeutic hypothermia to place umbilical lines.
-Arterial line, if indicated.
• Consult Neurology service for review of the history, examination of the neonate, and reading of an EEG/ aEEG monitoring for seizures.
-Cooling should not be delayed for the neurology service review, cranial ultrasound, or an EEG/aEEG evaluation.
Neurology Consultation and Evaluation
• Obtain head ultrasound (HUS) as soon as possible to evaluate for intracranial hemorrhage as a potential contraindication to continued cooling.
• Obtain an EEG/aEEG to assess for encephalopathy and seizures.
• Seizure control:
-First choice agent for treating seizures: phenobarbital.
-Confirmation with full-channel EEG is recommended as soon as possible.
-Continue video EEG recording for 24 hours or longer if seizures are detected.
• MR imaging:
-In consultation with neurology, determine optimal timing of MRI.
Medical Management Guidelines for Therapeutic Hypothermia After Admission to Accepting Center
STABILIZATION AND MANAGEMENT
© 2016 AMC PSO Laboratory Monitoring While Receiving Therapeutic Hypothermia
• Blood cultures should be obtained, as indicated.
• Other labs should be monitored per institutional protocol.
• Platelets:
-Thrombocytopenia is common in hypothermia.
-Due to the ongoing risk of cerebral hemorrhage, consider transfusing at a threshold platelet count of 50K.
• PT/PTT/INR should be checked as soon as possible.
• AST and ALT.
• Serum lactate, ideally from blood gas.
• Anti-epileptic levels, if indicated.
Fluid and Electrolytes
• Neonates should be kept NPO during hypothermia. At the attending's discretion, very small (non-nutritive priming) volumes of human breast milk may be given if the neonate is physiologically stable and no evidence of non-CNS organ dysfunction (i.e., good urine output, normal LF Ts and bowel sounds present).
• Start IV maintenance fluids, avoiding over-hydration. IV fluids should be restricted to avoid cerebral and pulmonary edema in the setting of compromised renal function. Typically, start at 60 mL/kg/24 hours and adjust based on strict ins/outs.
• Maintain glucose and electrolytes within normal limits. 
Respiratory
• Provide respiratory support as needed.
-Maintain arterial blood gas pCO 2 in range of 40-50 mmHg to optimize cerebral perfusion.
-If on supplemental oxygen, avoid hyperoxia.
-Target SaO 2 94-99%.
-Arterial PaO 2 should not exceed 100 mmHg.
• Of note: Suspected or proven pulmonary hypertension is not a contraindication to cooling and is not an indication for early rewarming. Pulmonary hypertension should be managed as per local protocol.
Infectious Disease
• If not already done in the community setting, evaluate for suspected sepsis and treat appropriately-avoid aminoglycosides.
• Correct coagulopathy prior to performing a lumbar puncture (LP).
• Consider obtaining CSF sample for investigation if suspicion of meningitis, or blood culture positive, or unexplained encephalopathy.
• Follow up on cultures and continue antibiotics.
• Monitor for fat necrosis and associated risk of hypercalcemia.
Maintain Adequate Sedation
• Indirect evidence supports that modest sedation during hypothermia improves neonatal outcome.
• Sedation:
-Consider low dose opiate sedation to avoid apnea.
-Avoid benzodiazepines.
-Refer to individual institutional guidelines for choice of opioid and dosing regimen.
-No standardized protocol sedation tool has been validated in this population.
Rewarming
• Begin after 72 hours of cooling.
• Rewarming should be done slowly. Increase core temperature 0.2-0.5 °C per hour until core temperature reaches 36.5 °C.
• There is an increased risk of seizures during rewarming. Consider EEG monitoring.
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